Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 28.78
(2.53%)
CNY 28.78
(2.53%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 153.41 Million CNY | -23.45% |
| 2022 | 200.41 Million CNY | 31.43% |
| 2021 | 152.48 Million CNY | -2.69% |
| 2020 | 156.69 Million CNY | 30.9% |
| 2019 | 119.7 Million CNY | 4.7% |
| 2018 | 114.33 Million CNY | 22.13% |
| 2017 | 93.61 Million CNY | 22.03% |
| 2016 | 76.71 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 233.59 Million CNY | 90.43% |
| 2024 Q3 | 210.94 Million CNY | -9.7% |
| 2024 Q1 | 122.66 Million CNY | -20.05% |
| 2023 Q4 | 153.41 Million CNY | 27.21% |
| 2023 FY | 153.41 Million CNY | -23.45% |
| 2023 Q3 | 120.59 Million CNY | -43.79% |
| 2023 Q2 | 214.53 Million CNY | -4.07% |
| 2023 Q1 | 223.64 Million CNY | 11.59% |
| 2022 Q4 | 200.41 Million CNY | 9.49% |
| 2022 Q3 | 183.05 Million CNY | -9.27% |
| 2022 Q2 | 201.74 Million CNY | 66.32% |
| 2022 Q1 | 121.29 Million CNY | -20.45% |
| 2022 FY | 200.41 Million CNY | 31.43% |
| 2021 FY | 152.48 Million CNY | -2.69% |
| 2021 Q1 | 131.2 Million CNY | -16.27% |
| 2021 Q4 | 152.48 Million CNY | 19.22% |
| 2021 Q3 | 127.9 Million CNY | -38.77% |
| 2021 Q2 | 208.87 Million CNY | 59.2% |
| 2020 Q3 | 87.3 Million CNY | -45.92% |
| 2020 Q1 | 103.2 Million CNY | -13.79% |
| 2020 FY | 156.69 Million CNY | 30.9% |
| 2020 Q4 | 156.69 Million CNY | 79.49% |
| 2020 Q2 | 161.42 Million CNY | 56.42% |
| 2019 Q4 | 119.7 Million CNY | 39.15% |
| 2019 Q3 | 86.02 Million CNY | -24.7% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 119.7 Million CNY | 4.7% |
| 2019 Q2 | 114.23 Million CNY | 0.0% |
| 2018 FY | 114.33 Million CNY | 22.13% |
| 2018 Q4 | 114.33 Million CNY | 0.0% |
| 2017 FY | 93.61 Million CNY | 22.03% |
| 2016 FY | 76.71 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | 533.75 Million CNY | 71.257% |